Key Details
Price
$2.66Annual ROE
45.94%Beta
1.87Events Calendar
Next earnings date:
May 30, 2025Recent quarterly earnings:
Nov 13, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Nov 20, 24 HC Wainwright & Co.
NeutralNov 15, 24 Wells Fargo
OverweightOct 10, 24 UBS
BuySep 19, 24 HC Wainwright & Co.
NeutralAug 15, 24 HC Wainwright & Co.
NeutralJul 31, 24 JP Morgan
OverweightJul 16, 24 HC Wainwright & Co.
NeutralJul 3, 24 HC Wainwright & Co.
NeutralMar 4, 24 Morgan Stanley
OverweightMar 4, 24 JP Morgan
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Kyverna Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Kyverna Therapeutics?
- Does Kyverna Therapeutics pay dividends?
- What sector is Kyverna Therapeutics in?
- What industry is Kyverna Therapeutics in?
- What country is Kyverna Therapeutics based in?
- When did Kyverna Therapeutics go public?
- Is Kyverna Therapeutics in the S&P 500?
- Is Kyverna Therapeutics in the NASDAQ 100?
- Is Kyverna Therapeutics in the Dow Jones?
- When was Kyverna Therapeutics's last earnings report?
- When does Kyverna Therapeutics report earnings?
- Should I buy Kyverna Therapeutics stock now?
What is the ticker symbol for Kyverna Therapeutics?
The ticker symbol for Kyverna Therapeutics is NASDAQ:KYTX
Does Kyverna Therapeutics pay dividends?
No, Kyverna Therapeutics does not pay dividends
What sector is Kyverna Therapeutics in?
Kyverna Therapeutics is in the Healthcare sector
What industry is Kyverna Therapeutics in?
Kyverna Therapeutics is in the Biotechnology industry
What country is Kyverna Therapeutics based in?
Kyverna Therapeutics is headquartered in United States
When did Kyverna Therapeutics go public?
Kyverna Therapeutics's initial public offering (IPO) was on February 9, 2024
Is Kyverna Therapeutics in the S&P 500?
No, Kyverna Therapeutics is not included in the S&P 500 index
Is Kyverna Therapeutics in the NASDAQ 100?
No, Kyverna Therapeutics is not included in the NASDAQ 100 index
Is Kyverna Therapeutics in the Dow Jones?
No, Kyverna Therapeutics is not included in the Dow Jones index
When was Kyverna Therapeutics's last earnings report?
Kyverna Therapeutics's most recent earnings report was on Nov 13, 2024
When does Kyverna Therapeutics report earnings?
The next expected earnings date for Kyverna Therapeutics is May 30, 2025
Should I buy Kyverna Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions